person

Ute K.

Country
Germany
Department
Klinik für Gastroenterologie, gastrointestinale Onkologie und Endokrinologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 9 partner sites.

Specializations

Gastrointestinal Oncology

Investigates therapeutic strategies for malignancies of the stomach, colon, pancreas, and biliary tract within gastrointestinal oncology.

  • advanced gastric cancer
  • colorectal carcinoma
  • pancreatic ductal adenocarcinoma
  • biliary tract cancer

Emphasizes targeted agents and immunotherapy to improve survival outcomes.

Hepatology and Liver Cancer

Focuses on primary liver malignancies and liver‑directed therapies under the umbrella of hepatology.

  • hepatocellular carcinoma
  • intrahepatic cholangiocarcinoma
  • liver metastases

Integrates systemic and locoregional treatment modalities to address tumor burden.

Endocrine and Metabolic Medicine

Addresses hormonal and metabolic disorders that intersect with gastrointestinal health, highlighted by endocrine and metabolic medicine.

  • type 2 diabetes mellitus
  • obesity
  • thyroid eye disease
  • Alport syndrome

Explores SGLT2 inhibition and metabolic pathway modulation as therapeutic avenues.

Inflammatory and Autoimmune Gastroenterology

Studies immune‑mediated gastrointestinal conditions and novel biologic interventions within inflammatory and autoimmune gastroenterology.

  • Crohn’s disease
  • ulcerative colitis
  • celiac disease
  • immune-mediated necrotizing myopathy

Focuses on cytokine blockade and strategies to achieve mucosal healing.

Cardiovascular‑Renal Interplay

Investigates cardiovascular and renal complications in patients with gastrointestinal and metabolic diseases, framed by cardiovascular‑renal interplay.

  • heart failure with reduced ejection fraction
  • chronic kidney disease
  • cardiorenal syndrome

Evaluates cardio‑protective agents in comorbid populations to mitigate organ cross‑damage.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.